Skip to main content

A weak Q1, but vaccines to drive strong recovery

Prolonged containment measures mean that activity in Emerging Europe will remain depressed for longer than we had previously expected. But the region is well-placed to access and distribute vaccines, which should allow activity to recover more quickly than in most other EM regions. The outlook is brightest in Central Europe, while Russia’s recovery will be held back by a tighter fiscal stance. Turkey’s central bank will keep monetary conditions tight, which will help it to claw back its battered credibility, although it will take the steam out of the economy. Inflation should ease sharply this year in Russia and Central Europe, and we think that interest rates will be kept low for longer than investors and most analysts currently expect.

Subscriber content

Read this in full, free

Start a free trial and use one of your 10 free starter credits to unlock this piece.


Free. 10 articles. No card required.

By completing this form you are agreeing to our Terms and Conditions for the provision of a free trial of Capital Economics' services. We take your privacy seriously and will not share your details with others without your consent. By providing your details, including your email address, you are consenting to Capital Economics sending you macroeconomic commentary and analysis. You can unsubscribe at any time. See our Privacy Policy for more information.